Status:
COMPLETED
Psychological Support for Patients With an Implantable Cardioverter Defibrillator
Lead Sponsor:
University Health Network, Toronto
Conditions:
Anxiety
Depression
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
About 30% of patients survive a cardiac arrest, and the majority of these receive an implantable cardioverter defibrillator (ICD) for prevention of sudden cardiac death (SCD). While ICD therapy offers...
Detailed Description
About 30% of patients survive a cardiac arrest, and the majority of these receive an implantable cardioverter defibrillator (ICD) for prevention of sudden cardiac death (SCD). While ICD therapy offers...
Eligibility Criteria
Inclusion
- Patients from either Toronto General hospital or St. Michael's Hospital who have coronary heart disease,
- Receiving their first ICD implant for secondary prevention of SCD or for primary prevention of SCD and their underlying heart disease was hypertrophic cardiomyopathy.
Exclusion
- Not able to read or understand English;
- Evidence of psychosis, dementia or cognitive impairment as documented in the patients' hospital records;
- Receiving an ICD for primary prevention of ICD.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
193 Patients enrolled
Trial Details
Trial ID
NCT00152763
Start Date
October 1 2003
End Date
November 1 2007
Last Update
January 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4